Part B Coding Coach: Perfect Your Injection and Infusion Claims With These Quick Tips

Why This Topic Matters

Injection and infusion claims are frequently scrutinized by payers, so understanding the broad coding categories covered in this article can help practices assess whether the full premium content is relevant to their workflow. The article also addresses payer variability and documentation topics that affect claim preparation for drug administration services.

Article Sections

1. Step 1: Choose the Proper Administration Code

   Introduces the first major coding topic: selecting among CPT administration services for injection and infusion claims. The section discusses how practices think about administration coding when drugs are given in different ways.

2. Tip: Check with payers when new drugs are introduced

   Covers payer-specific considerations when new medications enter the market and how coverage or coding preferences may vary. It also touches on timing, frequency, and authorization issues.

3. Step 2: Know When You Can Report a Separate E/M Code

   Explains the relationship between injection administration and separately reported evaluation and management services. The section focuses on documentation and general circumstances that affect whether an E/M service is considered separate.

4. Tip: Example and reporting considerations for separate E/M services

   Provides a practical discussion of how office visit coding may be considered alongside a drug administration encounter. It also notes related documentation and billing considerations.

5. Step 3: Don't Forget the Drug Supply Code

   Shifts to the drug product reporting piece of the claim and how HCPCS drug codes are used with administration services. The section also addresses drug naming, dosage reporting, and claim form information.

6. How it works

   Describes general workflow considerations for documenting frequently used drugs and associated claim details. The content remains focused on broad drug-reporting practices.

7. Example

   Presents a brief example related to drug supply reporting and administration coding. The example is meant to illustrate the topic at a high level.

8. No more LCA

   Discusses a payer policy update affecting drug reimbursement concepts. The section places the policy change in the context of drug administration claims.

9. Warning

   Highlights a billing caution involving patient-supplied drugs and claim submission. The section covers general compliance and documentation concerns.